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Abstract
Background: It is important to discriminate between primary and secondary lung cancer. However, often, the
discriminating diagnosis of primary lung acinar adenocarcinoma and lung metastasis of colorectal cancer based on
morphological and pathological findings is difficult. The purpose of this study was to evaluate the clinical usefulness
of immunohistochemistry of β-catenin, cytokeratin (CK) 7, and CK20 for the discriminating diagnosis of lung
cancer.
Methods: We performed immunohistochemistry of β-catenin, CK7, and CK20 in 19 lung metastasis of colorectal
cancer samples, 10 corresponding primary colorectal cancer samples and 11 primary lung acinar adenocarcinoma
samples and compared the levels of accuracy of the discriminating diagnosis by using antibodies against these
antigens.
Results: Positive staining of β-catenin was observed in all the lung metastasis of colorectal cancer samples as well
as in the primary colorectal cancer samples but in none of the primary lung acinar adenocarcinoma samples.
Positive staining of CK7 was observed in 90.9% of the primary lung acinar adenocarcinoma samples and in 5.3%
of the lung metastasis of colorectal cancer samples, but in none of the primary colorectal cancer samples. Positive
staining of CK20 was observed in all the primary colorectal cancer samples and in 84.2% of the lung metastasis of
colorectal cancer samples, but in none of the primary lung acinar adenocarcinoma samples.
Conclusion: Combined immunohistochemistry of β-catenin, CK7, and CK20 is useful for making a discriminating
diagnosis between lung metastasis of colorectal cancer and primary lung acinar adenocarcinoma. This method will
enable accurate diagnosis of a lung tumor and will be useful for selecting appropriate therapeutic strategies,
including chemotherapeutic agents and operation methods.
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After a colorectal cancer operation, metastatic liver cancer
is the most frequently observed cancer, followed by meta-
static lung cancer. However, it is occasionally difficult to
determine on the basis of clinical features whether the
lung tumor is a primary lung cancer or a lung metastasis
of colorectal cancer; this is because there are cases of lung
metastasis at the early stages of colorectal cancer and those
that occur more than 5 years after a colorectal cancer oper-
ation. Furthermore, the pathological features of primary
lung acinar adenocarcinoma are similar to those of differ-
entiated colorectal adenocarcinoma. Hence, the correct
diagnosis of a lung tumor is important for therapeutic
decision-making, such as the selection of chemotherapeu-
tic agents and operation methods.
β-catenin protein is a component of the Wnt signaling
pathway that regulates signal transduction in cell growth,
motility, and differentiation [1]. Recent studies have
shown that alterations in the Wnt signaling pathway,
including mutations in the adenomatous polyposis coli
(APC), β-catenin and Axin genes, play important roles in
the carcinogenesis of various malignant tumors [2]. Muta-
tions in these genes result in accumulation of the β-cat-
enin protein in the cytoplasm and the accumulated β-
catenin translocates into the nucleus [3]. Nuclear β-cat-
enin activates T-cell factor/lymphocyte enhancer binding
factor (TCF/LEF) family members and promotes the tran-
scriptions of their target genes such as c-myc and cyclin D1
[4,5]. It is interesting to note that alterations in the Wnt
signaling pathway exist in almost all cases of colorectal
cancer and result in nuclear accumulation of the β-catenin
protein [6-8].
Cytokeratin (CK) is one of the components of the intrac-
ytoplasmic cytoskeleton. The CKs constitute a family of
more than 30 polypeptides that are classified based on
their molecular weights and isoelectric points [9]. It has
been reported that CK is distributed in a tissue-specific
manner and that immunohistochemistry of certain CKs is
useful for the determination of tissues of origin in several
types of tumors [10].
This study was undertaken to evaluate the clinical useful-
ness of an immunohistochemical examination of β-cat-
enin as well as that of CK7 and CK20 for the
discriminating diagnosis of primary lung acinar adenocar-
cinoma and lung metastasis of colorectal cancer.
Methods
Tissue samples
Between 1992 and 2002, 269 lung operations for primary
lung cancer, 33 for lung metastasis of colorectal cancer,
and 725 for primary colorectal cancer were performed in
the Second Department of Surgery, Hiroshima University
Hospital. The pathological finding in 38 primary lung
cancer patients was acinar adenocarcinoma. The tissue
samples used in this study were obtained from these
patients. We analyzed 19 samples from patients with lung
metastasis of colorectal cancer, 10 from patients with pri-
mary colorectal cancer, and 11 from patients with primary
lung acinar adenocarcinoma; this was because, unfortu-
nately, several samples were lost and not available for use
in this study. Each sample was histologically assessed by a
pathologist based on the classification criteria followed by
WHO [11]. Ten tissue samples of primary colorectal can-
cer were obtained from the corresponding patients who
had undergone operations for lung metastasis of colorec-
tal cancer. We also analyzed a tissue sample of lung metas-
tasis of colorectal cancer obtained by needle biopsy from
a surgically resected lung tumor.
Immunohistochemistry of β-catenin, CK7, and CK20
Each tumor section (4 µm in thickness) was deparaffin-
ized and subjected to antigen retrieval by microwaving in
10 mM of citrate buffer (sodium citrate, pH 6.0) for 30
min. The sections were incubated with anti-β-catenin
(Transduction Laboratories, Lexington, KY), anti-CK7
(DAKO Corporation, Carpinteria, CA), and anti-CK20
(DAKO Corporation, Carpinteria, CA) monoclonal anti-
bodies at dilutions of 1:250, 1:100, and 1:100, respec-
tively, for 12 h at 4°C; and they were then stained by the
avidin-biotin complex method using a Histofine kit
(Nichirei, Tokyo, Japan). The results of β-catenin immu-
nostaining were based on nuclear and cytoplasmic stain-
ing and those of CK7 and CK20 were based on the
cytoplasmic staining of tumor cells. The β-catenin immu-
nostaining results were evaluated by comparing the stain-
ing intensities of tumor cells with those of the adjacent
non-tumor cells [12]. Immunostaining was defined as
positive when more than 10% of tumor cells were stained
by each antibody.
Results
Immunohistochemistry of β-catenin, CK7, and CK20
β-catenin staining was localized to the cell membrane and
was absent from the cytoplasm and nucleus of normal
colorectal epithelial cells, normal bronchial epithelial
cells, bronchial gland cells, and alveolar cells (data not
shown). Positive cytoplasmic and/or nuclear staining of
β-catenin was observed in all (100%) the 10 primary
colorectal cancer samples as well as in the 19 lung metas-
tasis of colorectal cancer samples, whereas positive
nuclear staining was detected in none of the 11 primary
lung acinar adenocarcinoma samples (Figure 1A, B, and
1C; Table 1). Three primary lung acinar adenocarcinoma
samples showed faint positive staining of β-catenin in the
cytoplasm; however, no staining was observed in the
nucleus (data not shown). CK7 staining was localized in
the cytoplasm in normal alveolar cells, but not in that ofPage 2 of 6
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CK7 was observed in 10 (90.9%) of the 11 primary lung
acinar adenocarcinoma samples but not in 18 (94.7%) of
the 19 lung metastasis of colorectal cancer samples nor in
any of the primary colorectal cancer samples (Figure 1D,
E, and 1F; Table 1). On the other hand, CK20 staining was
localized in the cytoplasm in normal colorectal epithelial
cells, but not in normal alveolar cells. Positive cytoplas-
mic staining of CK20 was observed in all (100%) the 10
primary colorectal cancer samples and in 16 (84.2%) of
the 19 lung metastasis of colorectal cancer samples, but in
none of the primary lung acinar adenocarcinoma samples
(Figure 1G, H, and 1I; Table 1).
Expression patterns of β-catenin, CK7, and CK20
The expression patterns obtained by the immunohisto-
chemical analysis are shown in Table 2. All (100%) the 10
primary colorectal cancer samples and 15 (78.9%) of the
19 lung metastasis of colorectal cancer samples showed a
β-catenin + / CK7 - / CK20 + pattern. Of the 19 lung
metastasis of colorectal cancer samples, 3 (15.8%) and 1
(5.3%) showed β-catenin + / CK7 - / CK20 - and β-catenin
+ / CK7 + / CK20 + patterns, respectively. Of the 11 pri-
mary lung acinar adenocarcinoma samples, 10 (90.9%)
and 1 (9.1%) showed β-catenin - / CK7 + / CK20 - and β-
catenin - / CK7 - / CK20 - patterns respectively. We com-
pared the levels of diagnostic accuracy of the stainings in
lung metastasis of colorectal cancer samples and in pri-
Immunohistochemical analysis of β-catenin, cytokeratin 7, and cytokeratin 20Figure 1
Immunohistochemical analysis of β-catenin, cytokeratin 7, and cytokeratin 20. (A) Positive nuclear staining of β-catenin in pri-
mary colorectal cancer. (B) Positive nuclear and cytoplasmic staining of β-catenin in lung metastasis of colorectal cancer. (C) 
Negative nuclear and cytoplasmic staining of β-catenin and positive membranous staining of β-catenin in primary lung acinar 
adenocarcinoma. (D and E) Negative staining of cytokeratin 7 in primary colorectal cancer and in lung metastasis of colorectal 
cancer. (F) Positive cytoplasmic staining of cytokeratin 7 in primary lung acinar adenocarcinoma. (G and H) Positive cytoplasmic 
staining of cytokeratin 20 in primary colorectal cancer and in lung metastasis of colorectal cancer. (I) Negative staining of 
cytokeratin 7 in primary lung acinar adenocarcinoma. Bar 50 µmPage 3 of 6
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diagnostic accuracy of β-catenin positive staining was
higher than that of the other combinations of immuno-
histochemical patterns. Furthermore, we performed
immunohistochemistry on a small sample obtained by
needle biopsy, and lung metastasis of colorectal cancer
was pathologically diagnosed. The results of immunohis-
tochemistry showed that β-catenin and CK20 were posi-
tive and CK7 was negative (data not shown).
Discussion
It is important to determine whether a lung tumor is pri-
mary or secondary lung cancer because the treatment
strategies for these two clinical situations are different.
However, it is occasionally difficult to make a discriminat-
ing diagnosis of primary lung acinar adenocarcinoma and
lung metastasis of colorectal cancer in lung tumor patients
who have previously undergone colorectal cancer opera-
tions. This study was therefore designed to determine
whether immunohistochemistry of β-catenin, CK7, and
CK20 is useful for the discriminating diagnosis of these
two clinical situations.
β-catenin is a key molecule not only in cadherin-depend-
ent cell-cell adhesion but also in the Wnt signaling path-
way [13]. The stability of the β-catenin protein is regulated
by the Wnt signaling pathway [1]. Glycogen synthase
kinase-3β phosphorylates β-catenin, and the phosphor-
ylated form of β-catenin is ubiquitinated and degraded by
the proteasome. Thus, the β-catenin protein is maintained
at a low level in normal cells. Alterations in the Wnt sign-
aling pathway, including mutations in the APC, β-catenin,
and Axin genes, result in an accumulation of β-catenin in
the nucleus. The APC gene is defined as a gatekeeper in the
adenoma-carcinoma sequence theory of colorectal car-
cinogenesis because APC alterations, such as mutations
and loss of heterozygosity, occur at an early stage of color-
ectal carcinogenesis [14]. It has been reported that altera-
tions in the APC gene are present in more than 80% of
colorectal cancer cases [6,7]. Furthermore, accumulation
of β-catenin in the nucleus and/or cytoplasm was detected
by immunohistochemistry in 80%–90% of colorectal
cancer cases [8,15,16]. Although a small number of the
samples were used in the present study, as expected, posi-
tive nuclear and/or cytoplasmic staining of β-catenin was
observed in all the primary colorectal cancer samples; this
is consistent with previous reports. The results of β-cat-
enin immunohistochemistry for lung metastasis of color-
ectal cancer samples were the same as those for primary
colorectal cancer samples. Further, the alterations in the
Wnt signaling pathway in lung cancer are unclear. It has
been reported that in lung cancer, mutations in the APC
gene are not frequent. However, frequent allelic loss at 5q,
in which the APC gene is located, and frequent hyper-
methylation in the promoter region of the APC gene have
been reported [17-20]. Although it is not known whether
such alterations in the APC gene affect the accumulation
of the β-catenin protein in the cytoplasm and/or nucleus,
accumulation of β-catenin was observed in none of the
primary lung acinar adenocarcinoma samples in the
present study. It has also been reported that immunohis-
tochemical positive staining of β-catenin in the nucleus
was observed in less than 10% of the primary non-small
cell lung adenocarcinoma samples [21], similar to our
finding. Our results indicate that immunohistochemistry
of β-catenin is useful for the discriminating diagnosis of
lung metastasis of colorectal cancer and primary lung aci-
nar adenocarcinoma.
There are many reports on the usefulness of immunohis-
tochemistry of CKs for the discriminating diagnosis of
tumors of different origins [22-27]. CKs constitute a fam-
ily of more than 30 polypeptides and are distributed in a
tissue-specific and differentiation-specific manner [9,10].
CK phenotyping by combined immunohistochemistry of
several CKs, particularly CK7 and CK20, is commonly
used in surgical pathology to determine the origin of a cell
type or tissue in which a malignant tumor has developed.
It is interesting to note that the CK phenotype is different
in each histological type of lung cancer, including adeno-
carcinoma, squamous cell carcinoma, and small cell carci-
noma [28]. It has been reported that CK7 is expressed in
97%–100% of primary lung adenocarcinoma cases and in
5%–27% of primary colon adenocarcinoma cases. In con-
trast, it has been reported that CK20 is expressed in 7%–
10% of primary lung adenocarcinoma cases and 92%–
100% of primary colon adenocarcinoma cases [10,23,26].
We also performed immunohistochemistry of CK7 and
CK20 in our samples, and our results are consistent with
those reported previously. The most common staining
Table 1: Results of Immunohistochemistry of β-catenin, CK 7 and CK 20.
Samples Total β-Catenin (%) CK 7 (%) CK 20 (%)
Primary colorectal cancer 10 100 0 100
Lung metastasis from colorectal cancer 19 100 5.3 84.2
Primary lung acinar adenocarcinoma 11 0 90.9 0
CK, cytokeratinPage 4 of 6
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+ / CK7 - / CK20 +. Of the 19 lung metastasis of colorectal
cancer samples used in our study, 78.9% showed β-cat-
enin + / CK7 - / CK20 +. We analyzed several combina-
tions of β-catenin, CK7, and CK20 immunohistochemical
patterns. The level of accuracy of the discriminating diag-
nosis of lung metastasis of colorectal cancer and primary
lung acinar adenocarcinoma based on the results of
immunohistochemistry of β-catenin alone was higher
than that of the discriminating diagnosis based on immu-
nohistochemistry of other combinations. However, it is
noteworthy that approximately 10% of primary colorectal
cancer and primary lung cancer samples showed negative
and positive staining of β-catenin, respectively [8,21]. Fur-
thermore, several samples showed uncommon staining
patterns of CK7 or CK20. Taken together, the results sug-
gest that combined immunohistochemistry of β-catenin,
CK7, and CK20 is useful for obtaining a more accurate dis-
criminating diagnosis than that obtained by using immu-
nohistochemistry of one of these antigens alone or in
other combinations. In addition to β-catenin, CK7, and
CK20, thyroid transcriptional factor-1 (TTF-1) may be a
useful marker for the discriminating diagnosis of lung
metastasis of colorectal cancer and primary lung acinar
adenocarcinoma. TTF-1 is a tissue-specific transcriptional
factor that plays pivotal roles in the differentiation and
morphogenesis of the lung and thyroid. It has been
reported that positive staining of TTF-1 was observed in
70%–90% of primary lung cancer cases, but not in lung
metastasis of colorectal cancer cases [29-31]. Since CK7
and TTF-1 are specific markers for primary lung cancer
and CK20 and β-catenin for colorectal cancer, combined
immunohistochemistry of these markers may be valuable
in discriminating diagnosis. However, it is important to
note that mucinous bronchioloalveolar carcinoma, which
is a subtype of lung adenocarcinoma, shows a different CK
phenotype. It has been reported that 60% of mucinous
bronchioloalveolar carcinoma cases showed CK7 + /
CK20 + and that it is difficult to distinguish mucinous
bronchioloalveolar carcinoma from mucinous colorectal
adenocarcinoma metastatic to the lung based on the CK7
and CK20 phenotype [32]. Furthermore, by using mate-
rial that was obtained from a tumor of lung metastasis of
colorectal cancer by needle biopsy, we succeeded in mak-
ing an accurate discriminating diagnosis based on the
results of immunohistochemistry of β-catenin, CK7, and
CK20. Transbronchial lung biopsy and CT-guided biopsy
are often performed to obtain a pathological diagnosis of
lung tumors. However, the amount of material obtained
is occasionally insufficient to enable a discriminating
diagnosis of primary and secondary lung cancers based on
pathological findings. However, immunohistochemical
examinations can be easily performed using only a small
amount of material, and the results enable accurate diag-
nosis in cases of lung tumors.
Conclusion
Combined immunohistochemistry of β-catenin, CK7,
and CK20 is useful for making a discriminating diagnosis
of lung metastasis of colorectal cancer and primary lung
acinar adenocarcinoma. It is often difficult to distinguish
a lung tumor from primary lung acinar adenocarcinoma
or lung metastasis of colorectal cancer on the basis of
pathological and morphological features, particularly
when a small amount of material is obtained. Immuno-
histochemistry with β-catenin as well as CK7 and CK20
antibodies is helpful for making a discriminating diagno-
sis, and an accurate diagnosis is important for appropriate
selection of therapeutic strategies in cases of lung tumors.
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